Global management of a common, underrated surgical task during the COVID-19 pandemic: Gallstone disease - An international survery
Data
2020Autor
Manzia, Tommaso Maria
Angelico, Roberta
Parente, Alessandro
Muiesan, Paolo
Tisone, Giuseppe
Al Alawy, Yousef
Jabba Arif, Abdul
Attia, Magdy
Bhati, Chandra
Battula R, Narendra
Kunnath Bonney, Glenn
Brooke-Smith, Mark
Derosas, Carlos
De Liguori Carino, Nicola
Ferretti, Stefano
Fiorani, Cristina
Gherardi, Dario
Hegab, Bassem
Hussain, Zaki
Ielpo, Benedetto
Iesari, Samuele
Lai, Quirino
Lainas, Panagiotis
Lauterio, Andrea
Lazzaro, Alessandra
Marudanayagam, Ravi
Nasralla, David
Nicolini, Daniele
Orlando, Giuseppe
Patrono, Damiano
Pitchaimuthu, Maheswaran
Polak, Wojciech
Marcacuzco Quinto, Alberto
Rai, Rakesh
Scalera, Irene
Schlegel, Andrea
Shanmugam, Vivek
Vitale, Alessandro
Widmer, Jeannette
Yannick, Deswysen
Metadata
Mostrar registro completo
Documentos PDF
Resumo
Background: Since the Coronavirus disease-19(COVID-19) pandemic, the healthcare systems are reallocating
their medical resources, with consequent narrowed access to elective surgery for benign conditions such as
gallstone disease(GD). This survey represents an overview of the current policies regarding the surgical management of patients with GD during the COVID-19 pandemic.
Methods: A Web-based survey was conducted among 36 Hepato-Prancreato-Biliary surgeons from 14 Countries.
Through a 17-item questionnaire, participants were asked about the local management of patients with GD since
the start of the COVID-19 pandemic.
Results: The majority (n = 26,72.2%) of surgeons reported an alarming decrease in the cholecystectomy rate for
GD since the start of the pandemic, regardless of the Country: 19(52.7%) didn't operate any GD, 7(19.4%)
reduced their surgical activity by 50–75%, 10(27.8%) by 25–50%, 1(2.8%) maintained regular activity.
Currently, only patients with GD complications are operated. Thirty-two (88.9%) participants expect these
changes to last for at least 3 months.
In 15(41.6%) Centers, patients are currently being screened for SARS-CoV-2 infection before cholecystectomy
[in 10(27.8%) Centers only in the presence of suspected infection, in 5(13.9%) routinely]. The majority of
surgeons (n = 29,80.6%) have adopted a laparoscopic approach as standard surgery, 5(13.9%) perform open
cholecystectomy in patients with known/suspected SARS-CoV-2 infection, and 2(5.6%) in all patients.
Conclusion: In the ongoing COVID-19 emergency, the surgical treatment of GD is postponed, resulting in a huge
number of untreated patients who could develop severe morbidity. Updated guidelines and dedicated pathways
for patients with benign disease awaiting elective surgery are mandatory to prevent further aggravation of the
overloaded healthcare systems.
Palabras clave
Gallstone disease; Cholecystectomy; Elective surgery; COVID-19 pandemic; SARS-CoV-2Link para o recurso
https://doi.org/10.1016/j.amsu.2020.07.021Collections
Estadísticas Google Analytics
Comments
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.